Ketobemidone
Ketobemidone is a synthetic opioid analgesic used for the treatment of moderate to severe pain. It was first synthesized in 1942 by the Danish pharmaceutical company Lundbeck. Ketobemidone is known for its rapid onset of action and is often used in clinical settings where quick pain relief is necessary.
Pharmacology[edit]
Ketobemidone works by binding to the opioid receptors in the central nervous system, which inhibits the transmission of pain signals. It has a similar mechanism of action to other opioids such as morphine and oxycodone. Ketobemidone is available in various forms, including tablets, injections, and suppositories.
Medical Uses[edit]
Ketobemidone is primarily used for the management of acute and chronic pain. It is particularly effective in treating pain associated with surgery, cancer, and severe injuries. Due to its potency, it is often reserved for cases where other pain medications are ineffective.
Side Effects[edit]
Common side effects of ketobemidone include nausea, vomiting, constipation, and drowsiness. More severe side effects can include respiratory depression, hypotension, and addiction. As with other opioids, there is a risk of developing tolerance and dependence with prolonged use.
Contraindications[edit]
Ketobemidone should not be used in patients with a history of opioid addiction, respiratory disorders, or severe liver disease. It is also contraindicated in patients who are allergic to ketobemidone or any of its components.
Legal Status[edit]
The legal status of ketobemidone varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and addiction. Healthcare providers must adhere to strict regulations when prescribing and dispensing this medication.
History[edit]
Ketobemidone was developed during World War II as an alternative to morphine, which was in short supply. It has since been used in various countries, particularly in Scandinavia, for pain management.
See Also[edit]
References[edit]
External Links[edit]
 | This medical article is a stub. You can help Wikipedia by adding missing information. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
